医療用バイオニックインプラント及びエクソスケルトンの世界市場

Future Market Insightsが発行した調査報告書(FUMI709050)
◆英語タイトル:Medical Bionic Implants And Exoskeletons Market: North America to Remain Dominant Regional Market Through 2027: Global Industry Analysis 2012–2016 and Opportunity Assessment 2017 - 2027
◆商品コード:FUMI709050
◆発行会社(リサーチ会社):Future Market Insights
◆発行日:2017年6月28日
◆ページ数:148
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Individual PriceUSD5,000 ⇒換算¥540,000見積依頼/購入/質問フォーム
Corporate PriceUSD7,500 ⇒換算¥810,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はFuture Market Insights社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Future Market Insights社の概要及び新刊レポートはこちらでご確認いただけます。

Future Market Insightsが発行した本調査レポートでは、医療用バイオニックインプラント及びエクソスケルトンの世界市場について調査・分析し、医療用バイオニックインプラント及びエクソスケルトンの世界市場動向、医療用バイオニックインプラント及びエクソスケルトンの世界市場規模、市場予測、セグメント別医療用バイオニックインプラント及びエクソスケルトン市場分析、地域別市場規模(北米市場、南米市場、アジア市場、日本市場、ヨーロッパ市場など)、競争状況、関連企業情報などを含め、以下の構成でお届け致します。
【レポートの概要】

Rising demand for exoskeletons and bionic limbs seen worldwide
The demand for bionic products has witnessed impressive growth primarily because of greater awareness amongst patients, especially geriatric patients who may suffer from diabetes and obesity. The number of amputations performed on a yearly basis is also rising, directly benefiting the global medical bionic implants and exoskeletons market. As per data from the National Center for Health Statistics, 185,000 amputations are conducted in the U.S. every year and roughly 2 million people in the country are currently living with a lost limb. Rapid advancements in the global medical bionic implants and exoskeletons market have led to new and improved robotics technology. Medical device makers are looking at emerging economies mainly because of their large populations and continued demand for bionic replacements. In addition, a greater number of amputations coupled with improved capabilities of high-tech biomaterial based implants is contributing to the growth of the medical bionic implants and exoskeletons market.

Government initiatives assist the medical bionic implants and exoskeletons market

National governments and regulatory bodies in several countries are taking collaborative measures to ensure that there is a constant demand for the medical bionic implants and exoskeletons market. The World Bank states that countries in the Asia-Pacific region and Europe have witnessed a marked rise in FDI. Emerging markets such as Malaysia, Mexico, Indonesia, and India have recorded much higher economic growth rates than developed nations. This is expected to drive higher investment across the healthcare sector in all of these countries, boosting the global medical bionic implants and exoskeletons market. Suppliers are hampered by budgetary constraints, yet they seek solutions that strike the perfect balance between quality and affordability for their end users. This has ensured high interest in organizations giving and exhibiting clinical, economical, and utilitarian solutions to potential clients.

Geriatric population typically has high limb amputation rates

The global geriatric population, particularly in developed nations should drive the demand for bionic prosthetic equipment as the risk of peripheral vascular disease, diabetes related gangrene cases, and osteoarthritis is higher amongst the older population. The elderly population is increasing across the globe and it is forecast to grow to nearly 2 billion in 2050 from just over 600 million in 2000. More than 4/5th of amputations are mainly due to diabetes and peripheral vascular disease and 65% amputations are on people above the age of 50 years.

Custom made bionics and advanced technologies are the trends to watch out for

Companies manufacturing custom implants in the global medical bionic implants and exoskeletons market compete in the field of traditional implants. However, custom made bionics are now available and they offer innumerable size and length options on account of the 3D printer and sensor technology. (Open Bionics being one example). In addition, manufacturers have focussed their attention on the production process and cost-effective design at the lowest possible cost, to sustain their competitive position in the global medical bionic implants and exoskeletons market. Mind-controlled bionic sensors are gaining a lot of traction now as they are specifically made to improve intra-operative flexibility, reduce stress-strain shielding, and increase motion range with biocompatibility and high-performance articulations. For e.g. – The Symbionic Leg by Ossur Corporate is the first bionic leg available in the global medical bionic implants and exoskeletons market. It is unique and novel as it joins a controlled power ankle with a microprocessor knee unit. An individual can dorsiflex their lower limbs and this significantly reduces the probability of falling.

Bionic forelimbs – a massive segment poised to be worth almost US$ 600 Mn

The bionic forelimbs/hand bionics segment is a critical component of the global medical bionic implants and exoskeletons market and is expected to be worth just over US$ 285 Mn in 2017. This is predicted to rise to nearly US$ 585 Mn by the end of the forecast period in 2027 largely due to a high CAGR of 7.4% for the decade. Manufacturers would do well to actively target the bionic forelimbs/hand bionics segment in the global medical bionic implants and exoskeletons market.

【レポートの目次】

Table Of Content

1. Executive Summary

1.1. Market Overview

1.2. Market Analysis

1.3. FMI Analysis and Recommendations

1.4. Wheel of Fortune

2. Market Introduction

2.1. Market Taxonomy

2.2. Market Definition

3. Medical Bionic Implants and Exoskeletons Market View Point

3.1. Macro-Economic Factors

3.2. Opportunity Analysis

3.3. Recent Market Developments

3.4. Amputation Statistics (2012-2016)

3.5. Reimbursement Scenario

4. North America Medical Bionic Implants and Exoskeletons Market Analysis 2012–2016 and Forecast 2017–2027

4.1. Introduction

4.2. Key Regulations

4.3. Pricing Analysis

4.4. Regional Market Dynamics

4.4.1. Drivers

4.4.2. Restraints

4.4.3. Trends

4.5. Historical Market Size (US$ Mn) By Country, 2012-2016

4.5.1. U.S.

4.5.2. Canada

4.6. Market Size (US$ Mn) Forecast By Country, 2017-2027

4.6.1. U.S.

4.6.2. Canada

4.7. Historical Market Size (US$ Mn) By Product, 2012-2016

4.7.1. Bionic Forelimbs/Hand Bionics

4.7.1.1. Wrist Bionics

4.7.1.2. Bionic Elbow Braces

4.7.1.3. Bionic Limbs

4.7.1.4. Bionic Fingers

4.7.2. Bionic Legs/Lower Limbs

4.7.2.1. Bionic Knee Braces

4.7.2.2. Ankle Bionics

4.7.2.3. Bionic Foot Below Knee

4.7.3. Bionic Exoskeletons and Suits

4.8. Market Size (US$ Mn) Forecast By Product Type, 2017-2027

4.8.1. Bionic Forelimbs/Hand Bionics

4.8.1.1. Wrist Bionics

4.8.1.2. Bionic Elbow Braces

4.8.1.3. Bionic Limbs

4.8.1.4. Bionic Fingers

4.8.2. Bionic Legs/Lower Limbs

4.8.2.1. Bionic Knee Braces

4.8.2.2. Ankle Bionics

4.8.2.3. Bionic Foot Below Knee

4.8.3. Bionic Exoskeletons and Suits

4.9. Historical Market Size (US$ Mn) By Mode, 2012-2016

4.9.1. Prosthetic Bionics

4.9.2. External Bionics

4.10. Market Size (US$ Mn) Forecast By Mode, 2017-2027

4.10.1. Prosthetic Bionics

4.10.2. External Bionics

4.11. Drivers and Restraints: Impact Analysis

4.12. Market Attractiveness Analysis

4.12.1. By Country

4.12.2. By Product Type

4.12.3. By Mode

4.13. Key Representative Market Participants

4.14. Key Participants Market Presence (Intensity Map)

5. Western Europe Medical Bionic Implants and Exoskeletons Market Analysis 2012–2016 and Forecast 2017–2027

5.1. Introduction

5.2. Key Regulations

5.3. Pricing Analysis

5.4. Regional Market Dynamics

5.4.1. Drivers

5.4.2. Restraints

5.4.3. Trends

5.5. Historical Market Size (US$ Mn) By Country, 2012-2016

5.5.1. Germany

5.5.2. United Kingdom

5.5.3. France

5.5.4. Italy

5.5.5. Spain

5.5.6. Nordic Region

5.5.7. Rest of Western Europe

5.6. Market Size (US$ Mn) Forecast By Country, 2017-2027

5.6.1. Germany

5.6.2. United Kingdom

5.6.3. France

5.6.4. Italy

5.6.5. Spain

5.6.6. Nordic Region

5.6.7. Rest of Western Europe

5.7. Historical Market Size (US$ Mn) By Product, 2012-2016

5.7.1. Bionic Forelimbs/Hand Bionics

5.7.1.1. Wrist Bionics

5.7.1.2. Bionic Elbow Braces

5.7.1.3. Bionic Limbs

5.7.1.4. Bionic Fingers

5.7.2. Bionic Legs/Lower Limbs

5.7.2.1. Bionic Knee Braces

5.7.2.2. Ankle Bionics

5.7.2.3. Bionic Foot Below Knee

5.7.3. Bionic Exoskeletons and Suits

5.8. Market Size (US$ Mn) Forecast By Product Type, 2017-2027

5.8.1. Bionic Forelimbs/Hand Bionics

5.8.1.1. Wrist Bionics

5.8.1.2. Bionic Elbow Braces

5.8.1.3. Bionic Limbs

5.8.1.4. Bionic Fingers

5.8.2. Bionic Legs/Lower Limbs

5.8.2.1. Bionic Knee Braces

5.8.2.2. Ankle Bionics

5.8.2.3. Bionic Foot Below Knee

5.8.3. Bionic Exoskeletons and Suits

5.9. Historical Market Size (US$ Mn) By Mode, 2012-2016

5.9.1. Prosthetic Bionics

5.9.2. External Bionics

5.10. Market Size (US$ Mn) Forecast By Mode, 2017-2027

5.10.1. Prosthetic Bionics

5.10.2. External Bionics

5.11. Market Size (US$ Mn) Forecast By Mode, 2017-2027

5.11.1. Implantable Bionics

5.11.2. External Bionics

5.12. Drivers and Restraints: Impact Analysis

5.13. Market Attractiveness Analysis

5.13.1. By Country

5.13.2. By Product Type

5.13.3. By Mode

5.14. Key Representative Market Participants

5.15. Key Participants Market Presence (Intensity Map)

6. Eastern Europe Medical Bionic Implants and Exoskeletons Market Analysis 2012–2016 and Forecast 2017–2027

6.1. Introduction

6.2. Key Regulations

6.3. Pricing Analysis

6.4. Regional Market Dynamics

6.4.1. Drivers

6.4.2. Restraints

6.4.3. Trends

6.5. Historical Market Size (US$ Mn) By Country, 2012-2016

6.5.1. Russia

6.5.2. Poland

6.5.3. Rest of Eastern Europe

6.6. Market Size (US$ Mn) Forecast By Country, 2017-2027

6.6.1. Russia

6.6.2. Poland

6.6.3. Rest of Eastern Europe

6.7. Historical Market Size (US$ Mn) By Product, 2012-2016

6.7.1. Bionic Forelimbs/Hand Bionics

6.7.1.1. Wrist Bionics

6.7.1.2. Bionic Elbow Braces

6.7.1.3. Bionic Limbs

6.7.1.4. Bionic Fingers

6.7.2. Bionic Legs/Lower Limbs

6.7.2.1. Bionic Knee Braces

6.7.2.2. Ankle Bionics

6.7.2.3. Bionic Foot Below Knee

6.7.3. Bionic Exoskeletons and Suits

6.8. Market Size (US$ Mn) Forecast By Product Type, 2017-2027

6.8.1. Bionic Forelimbs/Hand Bionics

6.8.1.1. Wrist Bionics

6.8.1.2. Bionic Elbow Braces

6.8.1.3. Bionic Limbs

6.8.1.4. Bionic Fingers

6.8.2. Bionic Legs/Lower Limbs

6.8.2.1. Bionic Knee Braces

6.8.2.2. Ankle Bionics

6.8.2.3. Bionic Foot Below Knee

6.8.3. Bionic Exoskeletons and Suits

6.9. Historical Market Size (US$ Mn) By Mode, 2012-2016

6.9.1. Prosthetic Bionics



【レポートのキーワード】

バイオニックインプラント、エクソスケルトン

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 医療用バイオニックインプラント及びエクソスケルトンの世界市場(Medical Bionic Implants And Exoskeletons Market: North America to Remain Dominant Regional Market Through 2027: Global Industry Analysis 2012–2016 and Opportunity Assessment 2017 - 2027)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆